Cohiro is a biotech compagny that specializes in inflammation and free radicals.
COHIRO offers fee-for-services research and development activities to companies involved in the production of pharmaceutical products and dietary complements and to the chemical industry.
COHIRO is a spin-off of the LPPCE (Laboratory of Experimental Cardiovascular Pharmacology and Pathophysiology) located in Faculty of Medicine and Pharmacy of the University of Burgundy in Dijon (France).
News
The Inflammasomes orchestrate the development of some side effects of obesity
In their article published in January 2012 (« The Inflammasome puts obesity in the Danger Zone », Cell Metabolism, 2012, 15, 10-18) R Stienstra and her colleagues review the precise role of inflammasome in the development of some side effects of obesity.
Cohiro develops business and scientific contacts in Europe and Canada.
After a series of face to face meetings with companies and university labs in Quebec in collaboration with UbiFrance (Montreal) followed by a Biopartnering congress in Vancouver ( see http://www.techvision.com/bpn/program/ ) in collaboration with UBIFrance Vancouver, and the Vitagora meeting in Dijon (see http://www.gout-nutrition-sante.com/ ) Cohiro will continue to develop its collaborative and fee for service network.
More news
Fee-for-services
COHIRO has developed a series of laboratory tests to establish the pharmacology and safety of your compounds.
More informationResearch and development
COHIRO conducts or manages more complex R&D activities alone or in collaboration with public research laboratories
More information